Drug intelligence / Profile preview

aprindine

Development stage
Unknown
Lead developer
Tianjin Institute of Pharmaceutical Research
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Aprindine is a long-acting Class Ib antiarrhythmic agent used primarily for the treatment of ventricular arrhythmias and, to a lesser extent, supraventricular arrhythmias. It acts by directly interfering with depolarization of the cardiac cell membrane through blockade of fast inward sodium channels, thereby reducing the rate of rise of the action potential and shortening repolarization. This elevates the fibrillation threshold and shortens the QT interval. Aprindine is effective when administered orally or intravenously and may be particularly useful in conditions such as Wolff-Parkinson-White syndrome. The drug is not approved in the United States but is available in some European countries and Japan[1][3][4][5][7][8].

Brand names
Aprindine Hydrochloride Capsules 10mg"NP"
Other names
aprindinaaprindinum
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on aprindine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aprindine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call